Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Comprehensive kinome NGS targeted expression profiling by KING-REX.

Carapezza G, Cusi C, Rizzo E, Raddrizzani L, Di Bella S, Somaschini A, Leone A, Lupi R, Mutarelli M, Nigro V, di Bernardo D, Magni P, Isacchi A, Bosotti R.

BMC Genomics. 2019 Apr 23;20(1):307. doi: 10.1186/s12864-019-5676-3.

2.

PATRI, a Genomics Data Integration Tool for Biomarker Discovery.

Ukmar G, Melloni GEM, Raddrizzani L, Rossi P, Di Bella S, Pirchio MR, Vescovi M, Leone A, Callari M, Cesarini M, Somaschini A, Della Vedova G, Daidone MG, Pettenella M, Isacchi A, Bosotti R.

Biomed Res Int. 2018 Jun 28;2018:2012078. doi: 10.1155/2018/2012078. eCollection 2018.

3.

Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.

Magnaghi P, Salom B, Cozzi L, Amboldi N, Ballinari D, Tamborini E, Gasparri F, Montagnoli A, Raddrizzani L, Somaschini A, Bosotti R, Orrenius C, Bozzi F, Pilotti S, Galvani A, Sommer J, Stacchiotti S, Isacchi A.

Mol Cancer Ther. 2018 Mar;17(3):603-613. doi: 10.1158/1535-7163.MCT-17-0324. Epub 2017 Dec 13.

4.

Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.

Bosotti R, Magnaghi P, Di Bella S, Cozzi L, Cusi C, Bozzi F, Beltrami N, Carapezza G, Ballinari D, Amboldi N, Lupi R, Somaschini A, Raddrizzani L, Salom B, Galvani A, Stacchiotti S, Tamborini E, Isacchi A.

Sci Rep. 2017 Aug 23;7(1):9226. doi: 10.1038/s41598-017-10044-3.

5.

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.

Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, Raddrizzani L, Palmeri L, Banfi P, Bonazzina E, Misale S, Marrapese G, Leone A, Alzani R, Luo D, Hornby Z, Lim J, Veronese S, Vanzulli A, Bardelli A, Martignoni M, Davite C, Galvani A, Isacchi A, Siena S.

J Natl Cancer Inst. 2015 Nov 12;108(1). pii: djv306. doi: 10.1093/jnci/djv306. Print 2016 Jan.

6.

The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.

Ardini E, Bosotti R, Borgia AL, De Ponti C, Somaschini A, Cammarota R, Amboldi N, Raddrizzani L, Milani A, Magnaghi P, Ballinari D, Casero D, Gasparri F, Banfi P, Avanzi N, Saccardo MB, Alzani R, Bandiera T, Felder E, Donati D, Pesenti E, Sartore-Bianchi A, Gambacorta M, Pierotti MA, Siena S, Veronese S, Galvani A, Isacchi A.

Mol Oncol. 2014 Dec;8(8):1495-507. doi: 10.1016/j.molonc.2014.06.001. Epub 2014 Jun 12.

7.

Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authentication.

Somaschini A, Amboldi N, Nuzzo A, Scacheri E, Ukmar G, Ballinari D, Malyszko J, Raddrizzani L, Landonio A, Gasparri F, Galvani A, Isacchi A, Bosotti R.

Genet Test Mol Biomarkers. 2013 Mar;17(3):254-9. doi: 10.1089/gtmb.2012.0359. Epub 2013 Jan 28.

PMID:
23356232
8.

Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

Balabanov S, Gontarewicz A, Keller G, Raddrizzani L, Braig M, Bosotti R, Moll J, Jost E, Barett C, Rohe I, Bokemeyer C, Holyoake TL, Brümmendorf TH.

PLoS One. 2011 Apr 26;6(4):e19164. doi: 10.1371/journal.pone.0019164.

9.

Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis.

Türeci O, Bian H, Nestle FO, Raddrizzani L, Rosinski JA, Tassis A, Hilton H, Walstead M, Sahin U, Hammer J.

FASEB J. 2003 May;17(8):836-47.

PMID:
12724343
10.

Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles.

Türeci O, Ding J, Hilton H, Bian H, Ohkawa H, Braxenthaler M, Seitz G, Raddrizzani L, Friess H, Buchler M, Sahin U, Hammer J.

FASEB J. 2003 Mar;17(3):376-85.

PMID:
12631577
11.

T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1.

Stassar MJ, Raddrizzani L, Hammer J, Zöller M.

Immunobiology. 2001 Aug;203(5):743-55.

PMID:
11563674
12.

Epitope scanning using virtual matrix-based algorithms.

Raddrizzani L, Hammer J.

Brief Bioinform. 2000 May;1(2):179-89.

PMID:
11465029
13.

In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program.

Cochlovius B, Stassar M, Christ O, Raddrizzani L, Hammer J, Mytilineos I, Zöller M.

J Immunol. 2000 Oct 15;165(8):4731-41.

14.

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices.

Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, Braxenthaler M, Gallazzi F, Protti MP, Sinigaglia F, Hammer J.

Nat Biotechnol. 1999 Jun;17(6):555-61.

PMID:
10385319
15.

Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM.

Raddrizzani L, Bono E, Vogt AB, Kropshofer H, Gallazzi F, Sturniolo T, Hämmerling GJ, Sinigaglia F, Hammer J.

Eur J Immunol. 1999 Feb;29(2):660-8.

16.

Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.

Raddrizzani L, Sturniolo T, Guenot J, Bono E, Gallazzi F, Nagy ZA, Sinigaglia F, Hammer J.

J Immunol. 1997 Jul 15;159(2):703-11.

PMID:
9218585
17.

Antigenic peptides and autoimmunity.

Sinigaglia F, Sturniolo T, Raddrizzani L, Hammer J.

APMIS. 1997 Feb;105(2):81-8. Review.

PMID:
9113069

Supplemental Content

Loading ...
Support Center